These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555 [TBL] [Abstract][Full Text] [Related]
10. Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies? Gil-Mohapel J; Simpson JM; Ghilan M; Christie BR Brain Res; 2011 Aug; 1406():84-105. PubMed ID: 21742312 [TBL] [Abstract][Full Text] [Related]
11. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T. Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981 [TBL] [Abstract][Full Text] [Related]
12. The presymptomatic phase of Huntington disease. Durr A; Gargiulo M; Feingold J Rev Neurol (Paris); 2012 Nov; 168(11):806-8. PubMed ID: 22902173 [TBL] [Abstract][Full Text] [Related]
14. Stereotaxic Surgical Targeting of the Nonhuman Primate Caudate and Putamen: Gene Therapy for Huntington's Disease. McBride JL; Clark RL Methods Mol Biol; 2016; 1382():409-28. PubMed ID: 26611603 [TBL] [Abstract][Full Text] [Related]
15. [The molecular bases of Huntington's disease: the role played by oxidative stress]. Tasset I; Sánchez F; Túnez I Rev Neurol; 2009 Oct 16-31; 49(8):424-9. PubMed ID: 19816846 [TBL] [Abstract][Full Text] [Related]
16. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation. Wade A; Jacobs P; Morton AJ Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944 [TBL] [Abstract][Full Text] [Related]
17. [Is Huntington's disease a neurological or psychiatric disorder? case report]. Dubas-Slemp H; Tylec A; Michałowska-Marmurowska H; Spychalska K Psychiatr Pol; 2012; 46(5):915-22. PubMed ID: 23394029 [TBL] [Abstract][Full Text] [Related]
18. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Gil JM; Rego AC Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572 [TBL] [Abstract][Full Text] [Related]
19. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136 [TBL] [Abstract][Full Text] [Related]
20. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]